Table 2.
References | Cancer site/stage | Study design | Sample size | Cancer management | Exercise intervention | Outcome assessment |
---|---|---|---|---|---|---|
Djuric et al.[9] | Breast; I-IIIA | RCT | 40 | Chemotherapy | Dietary management, tele-based motivational interviewing, pedometer-based walking | BMI, body fat percentage, waist circumference, weight, dietary fat intake, fatigue (FACT-G, FACT-B), total physical activity |
Pelekasis et al.[10] | Breast cancer; Stage I-IV | RCT | 61 | Chemotherapy | Pedometer-based walking (8300-10,000 steps), DB, PMR, dietary consulting, guided imagery, CBT | BMI, QoL (SRH, HLC), night sleep duration, sleep onset latency, DASS-21 score, and spiritual health (SWBS) |
Gokal et al.[11] | Breast cancer | RCT | 50 | Adjuvant and neoadjuvant chemotherapy | Home-based walking program (150 min/week) | Executive function (Stroop task), working memory (WAIS-III), attention (SART), and cognitive functioning (CFQ) |
RCT: Randomized controlled trial, BMI: Body mass index, FACT-G: Functional Assessment of Cancer Treatment-General, FACT-B: Functional Assessment of Cancer Treatment-Breast, DB: Diaphragmatic breathing, PMR: Progressive muscle relaxation, CBT: Cognitive behavioral therapy, SRH: Self-reported health, HLC: Health locus of control, DASS-21: Depression Anxiety Stress Scale-21, SWBS: Spiritual Well-Being Scale, WAIS-III: Wechsler Adult Intelligence Scale-III, SART: Sustained Attention to Response Task, CFQ: Cognitive Failures Questionnaire, QoL: Quality of life